CIK 0001551306
- Large accelerated filer
Progyny, Inc.
Sign in to watch- Ticker
- PGNY
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272220139
- Phone
- +1 212-888-3124
- Business address
- 1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
- Former names
- Auxogyn, Inc., Auxogyn Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,674,844
- in 10 filings, $22.0M under 10b5-1 plans
Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-24 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −464 | $35.00 | $16K | 83,483 |
| 2023-04-24 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −1,857 | 1,063,096 | ||
| 2023-04-24 | Schlanger David J Executive Chairman | Exercise or conversion | +10,224 | $0.91 | $9K | 83,711 |
| 2023-04-24 | Schlanger David J Executive Chairman | Sale | −10,224 | $35.00 | $358K | 73,487 |
| 2023-04-24 | Schlanger David J Executive Chairman | Exercise or conversion · Stock Option (Right to Buy) | −10,224 | 684,708 | ||
| 2023-04-21 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion 10b5-1 | +8,370 | $3.95 | $33K | 224,294 |
| 2023-04-21 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −8,370 | $35.01 | $293K | 215,924 |
| 2023-04-21 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −2,093 | $35.01 | $73K | 83,947 |
| 2023-04-21 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −8,370 | 1,064,953 | ||
| 2023-04-21 | Schlanger David J Executive Chairman | Exercise or conversion | +37,296 | $0.91 | $34K | 110,783 |
| 2023-04-21 | Schlanger David J Executive Chairman | Sale | −37,296 | $35.01 | $1.3M | 73,487 |
| 2023-04-21 | Schlanger David J Executive Chairman | Exercise or conversion · Stock Option (Right to Buy) | −37,296 | 694,932 | ||
| 2023-04-03 | Anevski Peter CHIEF EXECUTIVE OFFICER | Shares withheld for taxes | −7,977 | $32.12 | $256K | 215,924 |
| 2023-04-03 | Schlanger David J Executive Chairman | Shares withheld for taxes | −2,681 | $32.12 | $86K | 73,487 |
| 2023-03-09 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −79 | $34.37 | $3K | 56,949 |
| 2023-03-08 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion | +1,041 | $3.95 | $4K | 224,942 |
| 2023-03-08 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −1,041 | $35.00 | $36K | 223,901 |
| 2023-03-08 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −260 | $35.00 | $9K | 86,040 |
| 2023-03-08 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Stock Option (Right to Buy) | −1,041 | 1,073,323 | ||
| 2023-03-07 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion | +22,151 | $3.95 | $87K | 246,052 |
Page 27 of 77 · 1,524 trades